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technique been used with the aim of pre-
serving the marginal arteries.
In summary, therefore, the authors have
done no more than confirm that resection or
constriction at the apex has a strictly cos-
metic effect on ejection fraction and a neg-
ligible effect on global left ventricular
function. There is no need to invoke any
pivotal impact of the spiraling muscles pre-
sumed to be involved in ventricular filling
so as to explain the lack of therapeutic
benefit. Indeed, the authors have provided
no evidence of a major impairment of the
dynamics of the ventricular filling apart
from a moderate increase in the filling pres-
sure of the left ventricle and a decrease by
one tenth in stroke volume. In our opinion,
this latter finding is more likely due to the
overcorrection of the volume of the ventri-
cle by reducing its long axis. They should
remember that clinical results have now
provided ample evidence that when the left
ventricle is dilated, resection of any part of
its walls, including the septum, is tolerated
without impairing left ventricular func-
tion.3-6 Indeed, a marked improvement in
left ventricular function is achieved when-
ever the radius of the upper two thirds of
the left ventricle is significantly reduced.
The conclusions drawn by the authors,
namely, that surgical intervention on the
left ventricular apex is markedly detrimen-
tal, are not, in our opinion, supported by
their experimental evidence.
P. P. Lunkenheimera
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Reply to the Editor:
Savage and colleagues’ study1 demon-
strated that volume reduction surgery
(VRS) in a model of left ventricular (LV)
aneurysm without global LV dysfunction
plicated only LV apex. On the other hand,
apex-sacrificing VRS in our series reduced
the diameter of not only LV apex but also
LV mid-portion in a model of global LV
dysfunction. The effects of volume reduc-
tion in akinetic or dyskinetic area are dif-
ferent from hypokinetic area.2 Drs Lunken-
heimer and Anderson support reduction of
the radius of the ventricle in its upper two
thirds (ie, basal). We agree with them on
that point, and reduction of the upper two
thirds of left ventricle is the same as our
apex-sparing VRS. In clinical series, how-
ever, no one has described or advocated
reduction of the radius of the ventricle in its
upper two thirds. The letter by Drs Lunken-
heimer and Anderson focused on the issue
in LV aneurysm or ischemic cardiomyop-
athy (raised by Savage and colleagues1),
but the disease that we studied via this
animal model was dilated cardiomyopathy
(ie, nonischemic). From this viewpoint,
their criticism is interesting and important
but misdirected.
Konertz and coworkers3 reported excel-
lent results of VRS but they also did not
described reduction of the upper two thirds
of left ventricle, and a majority of their
cases are ischemic cardiomyopathy. Again,
our study was focused on the dilated car-
diomyopathy (nonischemic cardiomyopa-
thy, a different disease). It is difficult to
adopt their results to our study.
Theoretically the therapeutic effect of
reducing ventricular radius is at least in
part dependent on the degree of preexisting
ventricular dilation. In the clinical setting,
however, operative mortality is high and
LV redilatation and dysfunction are not
rare after VRS.4-10 This suggests that the
theoretical concept is not necessarily repro-
ducible in the clinical situation and that the
way to excise and repair the LV is also
important. Although there are some limita-
tions due to the model of acute heart failure
induced by -blocker, the heart rate before
and after VRS was statistically no different
between the 2 groups. LV contractility in
apex-sparing VRS was shown to be supe-
rior to apex-sacrificing VRS, and LV end-
diastolic pressure was lower in apex-spar-
ing VRS. Those differences between the 2
groups were significant.
Batista’s group described an incision
made at the apex of the left ventricle. In our
article,2 we never stated that Batista and
colleagues advocated the apex resection,
but they did not try to preserve the apex as
much as possible. In fact, Lunkenheimer
and colleagues11 use the term “oyster-
shaped excision” in their case report, fol-
lowing the scheme of Batista’s operation
by widely resecting the LV apex. Through-
out our article we tried to show the poten-
tial pitfall of the great operation described
by Batista and colleagues and to improve
it. There would be some ischemic damage
extending beyond the plicated segment in
VRS, and we have described plication ef-
fects in the adjacent area in our study lim-
itation. It is unknown, however, whether
the ischemic damage follows according to
the position of resection or plication area.
However, this potential concern of com-
promising the marginal arteries is equally
applicable to conventional Batista proce-
dure. Further investigation would be war-
ranted.
We have already demonstrated these 2
types of VRS in a model of chronic dilated
cardiomyopathy.12 Elevation of LV end-
diastolic pressure and LV redilatation were
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remarkable from 1 week after apex-sacri-
ficing VRS but not in apex-sparing VRS.
Drs Lunkenheimer and Anderson described
in their letter that resection of any part of
LV wall, including the septum, is tolerated
without impairing LV function when the
left ventricle is dilated. However, septal
anterior ventricular exclusion or pacopexy
reduces the septal and anterior wall without
amputating the LV apex and yields good
clinical results.13,14 We think those results
are compatible with our study.
In addition, results of some clinical
cases that underwent the apex-sparing VRS
in our unit have been excellent so far. Thus
we believe that it is important to reduce the
LV volume in dilated left ventricle with
severe LV dysfunction. Apex-sparing VRS
may improve the clinical results.
Although the hypothesis by Dr Torrent-
Guasp and colleagues is very interesting,15
there is no scientific proof so far. Therefore
the relationship between cause and result in
the improved LV function after the apex-
sparing VRS and preservation of single
muscle band is still unknown, and further
study will be required.
Tadaaki Koyama, MD, PhD
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Study of warm perfusion rather than
cardioplegia
To the Editor:
I read the article by Mallidi and col-
leagues,1 “The Short-term and Long-term
Effects of Warm or Tepid Cardioplegia,”
and raise the following concern. The title is
not descriptive of the protocols. Rather
than isolated cold or warm cardioplegia,
the article really describes cold and warm
total-body and cardiac perfusion strategies.
The article states, “In the warm or tepid
blood cardioplegia group, the systemic
temperature was maintained at 33°C to
37°C, and the blood cardioplegia was de-
livered at a temperature of 37°C. In the
tepid cardioplegia group, the systemic tem-
perature was permitted to drift passively
during the operation to 32°C to 34°C. The
temperature of the cardioplegia was 28° to
30°C. In the cold cardioplegia group, the
systemic temperature was actively cooled
to 25°C to 32°C, and the blood cardiople-
gia was actively cooled to a temperature of
5°C to 8°C.”
Other combinations may have similar
results, for example a warm corporeal per-
fusion strategy (drifting without active
cooling) and cold cardioplegia. The data do
not preclude such a result.
This group has done a nice job scientif-
ically studying and promoting warm perfu-
sion and protection strategies. I think that
describing their technique as “warm blood
cardioplegia” does not describe the strategy
adequately, and “warm perfusion strategy”
might be more accurate.
Edward B. Savage, MD
Rush–Presbyterian–St Luke’s Medical Center
Chicago, IL 60612
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Reply to the Editor:
Dr Savage correctly points out that the ar-
ticle published in the March issue of the
Journal by our group was not simply a
comparison of cold versus warm or tepid
cardioplegia, but rather a comparison of the
strategy of warm or tepid cardioplegia ver-
sus cold cardioplegia. The three cardiople-
gic and systemic perfusion strategies used
in patients undergoing isolated coronary
artery grafting surgery at our institution
were described in detail in the article. Other
possible cardioplegic and systemic perfu-
sion strategies (such as warm systemic per-
fusion with cold cardioplegia, tepid sys-
temic perfusion with cold cardioplegia,
systemic hypothermia with warm or tepid
cardioplegia, and so on) were not used in
our institution.
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